Literature DB >> 27759030

Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype.

Fanny Morice-Picard1,2, Giovanni Benard3, Hamid R Rezvani4, Eulalie Lasseaux5, Delphine Simon3, Sébastien Moutton3, Caroline Rooryck3,5, Didier Lacombe3, Clarisse Baumann6, Benoit Arveiler3,5.   

Abstract

The ubiquitin-proteasome pathway is involved in the pathogenesis of several neurogenetic diseases. We describe a Mauritanian patient harboring a homozygous deletion restricted to two contiguous genes HERC2 and OCA2 and presenting with severe developmental abnormalities. The deletion causes the complete loss of HERC2 protein function, an E3-ubiquitin ligase. HERC2 is known to target XPA and BRCA1 for degradation and a mechanism whereby it is involved in DNA repair and cell cycle regulation. We showed that loss of HERC2 function leads to the accumulation of XPA and BRCA1 in the patient's fibroblasts and generates decreased sensitivity to apoptosis and increased level of DNA repair. Our data describe for the first time the phenotypic consequences, both at the clinical and cellular levels, of a complete loss of HERC2 function in a patient. They strongly suggest that profound ubiquitin ligase - associated dysfunction is responsible for the severe phenotype in this patient, and that dysfunction of this pathway may be involved in other patients with similar neurodevelopmental diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27759030      PMCID: PMC5159772          DOI: 10.1038/ejhg.2016.139

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

Review 1.  The HERC proteins: functional and evolutionary insights.

Authors:  F R Garcia-Gonzalo; J L Rosa
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

2.  A nonsense variant in HERC1 is associated with intellectual disability, megalencephaly, thick corpus callosum and cerebellar atrophy.

Authors:  Lam Son Nguyen; Taiane Schneider; Marlène Rio; Sébastien Moutton; Karine Siquier-Pernet; Florine Verny; Nathalie Boddaert; Isabelle Desguerre; Arnold Munich; José Luis Rosa; Valérie Cormier-Daire; Laurence Colleaux
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

3.  Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2.

Authors:  Simone Kühnle; Ulrike Kogel; Sandra Glockzin; Andreas Marquardt; Aaron Ciechanover; Konstantin Matentzoglu; Martin Scheffner
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

4.  High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene.

Authors:  Fanny Morice-Picard; Eulalie Lasseaux; Dorothée Cailley; Audrey Gros; Jérome Toutain; Claudio Plaisant; Delphine Simon; Stéphane François; Brigitte Gilbert-Dussardier; Josseline Kaplan; Caroline Rooryck; Didier Lacombe; Benoit Arveiler
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-23       Impact factor: 4.693

5.  The relative cytotoxicity of (6-4) photoproducts and cyclobutane dimers in mammalian cells.

Authors:  D L Mitchell
Journal:  Photochem Photobiol       Date:  1988-07       Impact factor: 3.421

6.  Mutation of HERC2 causes developmental delay with Angelman-like features.

Authors:  Gaurav V Harlalka; Emma L Baple; Harold Cross; Simone Kühnle; Monica Cubillos-Rojas; Konstantin Matentzoglu; Michael A Patton; Karin Wagner; Roselyn Coblentz; Debra L Ford; Deborah J G Mackay; Barry A Chioza; Martin Scheffner; Jose Luis Rosa; Andrew H Crosby
Journal:  J Med Genet       Date:  2012-12-14       Impact factor: 6.318

7.  A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder.

Authors:  Erik G Puffenberger; Robert N Jinks; Heng Wang; Baozhong Xin; Christopher Fiorentini; Eric A Sherman; Dominick Degrazio; Calvin Shaw; Carrie Sougnez; Kristian Cibulskis; Stacey Gabriel; Richard I Kelley; D Holmes Morton; Kevin A Strauss
Journal:  Hum Mutat       Date:  2012-12       Impact factor: 4.878

8.  A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice.

Authors:  A L Lehman; Y Nakatsu; A Ching; R T Bronson; R J Oakey; N Keiper-Hrynko; J N Finger; D Durham-Pierre; D B Horton; J M Newton; M F Lyon; M H Brilliant
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein.

Authors:  Tae-Hong Kang; Joyce T Reardon; Aziz Sancar
Journal:  Nucleic Acids Res       Date:  2010-12-30       Impact factor: 16.971

10.  Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.

Authors:  Jeffrey T Galligan; Gustavo Martinez-Noël; Verena Arndt; Sebastian Hayes; Thomas W Chittenden; J Wade Harper; Peter M Howley
Journal:  J Proteome Res       Date:  2014-12-15       Impact factor: 4.466

View more
  10 in total

1.  Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

Authors:  Gustavo Martínez-Noël; Katja Luck; Simone Kühnle; Alice Desbuleux; Patricia Szajner; Jeffrey T Galligan; Diana Rodriguez; Leon Zheng; Kathleen Boyland; Flavian Leclere; Quan Zhong; David E Hill; Marc Vidal; Peter M Howley
Journal:  J Mol Biol       Date:  2018-02-06       Impact factor: 5.469

2.  Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.

Authors:  Nikhil J Pandya; Congwei Wang; Veronica Costa; Paul Lopatta; Sonja Meier; F Isabella Zampeta; A Mattijs Punt; Edwin Mientjes; Philip Grossen; Tania Distler; Manuel Tzouros; Yasmina Martí; Balazs Banfai; Christoph Patsch; Soren Rasmussen; Marius Hoener; Marco Berrera; Thomas Kremer; Tom Dunkley; Martin Ebeling; Ben Distel; Ype Elgersma; Ravi Jagasia
Journal:  Cell Rep Med       Date:  2021-08-17

Review 3.  HERCing: Structural and Functional Relevance of the Large HERC Ubiquitin Ligases.

Authors:  Jesús García-Cano; Arturo Martinez-Martinez; Joan Sala-Gaston; Leonardo Pedrazza; Jose Luis Rosa
Journal:  Front Physiol       Date:  2019-08-07       Impact factor: 4.566

4.  Novel loss-of-function mutation in HERC2 is associated with severe developmental delay and paediatric lethality.

Authors:  Marilena Elpidorou; Sunayna Best; James A Poulter; Verity Hartill; Emma Hobson; Eamonn Sheridan; Colin A Johnson
Journal:  J Med Genet       Date:  2020-06-22       Impact factor: 6.318

5.  Study on the Correlation Between Iris Characteristics and Schizophrenia.

Authors:  Chunsheng Tian; Li Duan; Chunfeng Fu; Juan He; Jiali Dai; Gang Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-08       Impact factor: 2.570

Review 6.  The mechanisms of ferroptosis and its role in alzheimer's disease.

Authors:  Hongyue Ma; Yan Dong; Yanhui Chu; Yanqin Guo; Luxin Li
Journal:  Front Mol Biosci       Date:  2022-08-26

7.  HERC2 deficiency activates C-RAF/MKK3/p38 signalling pathway altering the cellular response to oxidative stress.

Authors:  Joan Sala-Gaston; Leonardo Pedrazza; Juanma Ramirez; Arturo Martinez-Martinez; Lettie E Rawlins; Emma L Baple; Andrew H Crosby; Ugo Mayor; Francesc Ventura; Jose Luis Rosa
Journal:  Cell Mol Life Sci       Date:  2022-10-14       Impact factor: 9.207

8.  ASPM promotes homologous recombination-mediated DNA repair by safeguarding BRCA1 stability.

Authors:  Shibin Xu; Xingxuan Wu; Peipei Wang; Sheng-Li Cao; Bin Peng; Xingzhi Xu
Journal:  iScience       Date:  2021-05-12

Review 9.  E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration.

Authors:  Arun Upadhyay; Vibhuti Joshi; Ayeman Amanullah; Ribhav Mishra; Naina Arora; Amit Prasad; Amit Mishra
Journal:  Front Mol Neurosci       Date:  2017-05-19       Impact factor: 5.639

10.  Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.

Authors:  Jesús García-Cano; Susana Sánchez-Tena; Joan Sala-Gaston; Agnès Figueras; Francesc Viñals; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  Mol Oncol       Date:  2019-11-15       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.